Current Signal Transduction Therapy,volume 3,issue 3  (01-2008)

Period of time： 2008年3期

Publisher： Bentham Science Publishers

Founded in： 2006

Total resources： 31

E-ISSN： 2212-389x|3|3

ISSN： 1574-3624

Subject：

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Signal Transduction Therapy,volume 3,issue 3

Menu

Alzheimer's Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 152-157

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Unravelling the Complicated Networks of Integrin IIb&bgr;3 Signalling in Platelets

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-01 , pp. 158-167

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Bypassing Cancer Resistance by Antagonizing “Inhibitor of Apoptosis Proteins” (IAPs)

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 168-173

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

G Protein-Coupled Receptor-Receptor Tyrosine Kinase Receptor Crosstalk: Regulation of Receptor Sensitivity and Roles of Autocrine Feedback Loops and Signal Integration

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 174-182

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pharmacological Modulation of p53 Function in Cancer Therapy

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 183-194

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

GSK-3 Inhibitors: Recent Developments and Therapeutic Potential

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 195-205

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Shared Signaling Pathways Between Endocrine and Immune System Receptors: The Model of Gamma Chain

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 206-214

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Possible Exploitation of Non-Neuronal and Non-Chemical Synaptic Signalling Pathways in Epilepsy Therapy

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 215-230

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Signal Transduction Pathway Regulated by Genistein and its Therapeutic Use

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 231-233

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer

Current Signal Transduction Therapy,volume 3,issue 3 , Vol. 3, Iss. 3, 2008-09 , pp. 234-243

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)